Stryker Corporation company logo

# RNN 2nd Gen Model Stryker Corporation Surgical & medical instruments

Prediction models:
Subscribe >> Deal exit on
July 17, 2019
Deal entry on
July 17, 2019
18.82%Expected margin
0.00% successful of 1 deals
$ 205.40 Last close price
at 16-jul-2019


Model's trade recommendations No return for period yet

-0.52% Annual return

$62.42B Market Cap

β 0.70  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period
52wk return 16.05%
52wk Range
Sortino ratio -1.18
Sharpe ratio -1.18
Norm. RMSE 18.29%
Downside risk 0.72%
Volatility 0.00%
  • 1.88 (1.13%) Div (Yield)
  • BUY Analysts consensus recommendation

Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.

Industry sector: Medical

Sector classification: Surgical & medical instruments

Deep Learning based analysis and prediction model for Stryker Corporation (SYK) stock is a 2nd Generation Non-linear Autoregressive (NAR) model based on the LSTM/GRU Recurrent Neural Network architecture.

Model is in the production pipeline since Sept. 19, 2017.

Market data for SYK model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a regular basis.

Float 346M
P/E 24.97
Shares Outstanding 374M
% Held by Insiders 7.40%
% Held by Institutions 75.62%
EPS (last reported FY) $6.49
EPS (last reported Q) $1.68
EPS, estimated (last reported Q) $1.60
Total revenues $12 B
Net income $1 B